WASHINGTON — The Trump administration on Tuesday evening unveiled the prices for 15 drugs that were the subject of Medicare negotiations for the second year, saying it saved $8.5 billion, or 36%, compared to what it would’ve paid last year had the negotiated prices been in effect.

Officials took pains to play up their negotiating prowess as superior to that of their counterparts in the Biden administration. The program, part of the Inflation Reduction Act, is a signature achievement of the Biden administration.

“This year’s results stand in stark contrast to last year’s,” CMS Administrator Mehmet Oz said in a statement. “Using the same process with a bolder direction, we have achieved substantially better outcomes for taxpayers and seniors in the Medicare Part D program — not the modes

See Full Page